4GLS

Crystal Structure of Chemically Synthesized Heterochiral {D-Protein Antagonist plus VEGF-A} Protein Complex in space group P21

4GLS の概要

• エントリーDOI: 10.2210/pdb4gls/pdb
• 関連するPDBエントリー: 3QTK 4GLN 4GLU
• 分子名称: D- Vascular endothelial growth factor-A, L- RFX001, D- RFX001, ... (7 entities in total)
• 機能のキーワード: heterochiral protein-protein complex, d-protein antagonist, growth factor-inhibitor complex, growth factor/inhibitor
• 細胞内の位置: Secreted: P15692
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 73492.41

構造登録者

Mandal, K.,Uppalapati, M.,Ault-Riche, D.,Kenney, J.,Lowitz, J.,Sidhu, S.,Kent, S.B.H. (登録日: 2012-08-14, 公開日: 2012-09-05, 最終更新日: 2024-11-20)

主引用文献

Mandal, K.,Uppalapati, M.,Ault-Riche, D.,Kenney, J.,Lowitz, J.,Sidhu, S.S.,Kent, S.B.
Chemical synthesis and X-ray structure of a heterochiral {D-protein antagonist plus vascular endothelial growth factor} protein complex by racemic crystallography.
Proc.Natl.Acad.Sci.USA, 109:14779-14784, 2012

PubMed Abstract: Total chemical synthesis was used to prepare the mirror image (D-protein) form of the angiogenic protein vascular endothelial growth factor (VEGF-A). Phage display against D-VEGF-A was used to screen designed libraries based on a unique small protein scaffold in order to identify a high affinity ligand. Chemically synthesized D- and L- forms of the protein ligand showed reciprocal chiral specificity in surface plasmon resonance binding experiments: The L-protein ligand bound only to D-VEGF-A, whereas the D-protein ligand bound only to L-VEGF-A. The D-protein ligand, but not the L-protein ligand, inhibited the binding of natural VEGF(165) to the VEGFR1 receptor. Racemic protein crystallography was used to determine the high resolution X-ray structure of the heterochiral complex consisting of {D-protein antagonist + L-protein form of VEGF-A}. Crystallization of a racemic mixture of these synthetic proteins in appropriate stoichiometry gave a racemic protein complex of more than 73 kDa containing six synthetic protein molecules. The structure of the complex was determined to a resolution of 1.6 Å. Detailed analysis of the interaction between the D-protein antagonist and the VEGF-A protein molecule showed that the binding interface comprised a contact surface area of approximately 800 Å(2) in accord with our design objectives, and that the D-protein antagonist binds to the same region of VEGF-A that interacts with VEGFR1-domain 2.

PubMed: 22927390
DOI: 10.1073/pnas.1210483109

実験手法

X-RAY DIFFRACTION (1.6 Å)